No sure if I follow you here tcm55..
SK was a completely different trial, it started because Algernon apparently wanted to "get the ball rolling" and a chance at dosing patients (Ifenprodil was an already approved drug in SK and Japan, but the chose SK because Japan was too expensive to run a trial). At the time of enrolment, South Korea was already the best country in the world at containment. It really appears (I'm not saying it was) to some that the whole SK news was to pump the stock for a PP.
Now, in regards to Australia. Australia is part of the 2b/3 multinational trial, not a separate trial as you applied in your post!
Australia, what is taking so long? Algernon applied for ethics approval way before they applied to the FDA, and still no reply? Australia has hardly any covid19 patients, why bother? Oh wait.. NOVOTECH!
Let's talk about Canada, they applied to HC and got approval on April 30th. At the time Canada was full blown epidemic, this is a Canadian company, and they have yet to dose a patient in Canada? After 63 days?
Now let's talk about The US, they recieved FDA approval on June 5th, 27 days ago. Since then, the only real news we got is they are adding two new countries to their multinational trial, still nobody dosed.
Let me illiterate:
Algernon 2b/3 multinational trial, 5 countries involved,
Canada (approved)
U. S. (approved)
Australia (pending)
Romania (pending)
Philippines (pending)
Out of the 5 countries listed above, 2 have the most daily cases, Can and the US. And the ONLY 2 countries approved for trials are Can and the U. S.
Yet we still wait.. Seems to me Algernon is not too keen in dosing on this continent for some reason - Novotech.
Fishy.
Jmo
B. O. B.
